Cite
Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study.
MLA
Morin, Laurence, et al. “Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study.” Current Oncology, vol. 31, no. 8, Aug. 2024, pp. 4624–31. EBSCOhost, https://doi.org/10.3390/curroncol31080345.
APA
Morin, L., Grenier, L.-P., Foucault, N., Lévesque, É., Fabi, F., Langlais, E.-L., Sebastianelli, A., Lavoie, M., Lalancette, M., Plante, M., Singbo, M. N. U., & Castonguay, V. (2024). Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study. Current Oncology, 31(8), 4624–4631. https://doi.org/10.3390/curroncol31080345
Chicago
Morin, Laurence, Louis-Philippe Grenier, Nicolas Foucault, Éric Lévesque, François Fabi, Eve-Lyne Langlais, Alexandra Sebastianelli, et al. 2024. “Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study.” Current Oncology 31 (8): 4624–31. doi:10.3390/curroncol31080345.